Cell Trials Data Selects Sentien’s Ph 1/2 Study of SBI-101 for AKI as Its Featured Advanced Cell Therapy Trial

In September, our clinical trial was selected by Cell Trials Data as its Featured Advanced Cell Therapy Trial.  Check it out here!